BackLabGenomics , Ltd. Overview

LabGenomics , Ltd. EBIT

Latest ebit for 084650.KQ: $-67B, below the sector sector average of $2.4T.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$6.87B
↓ 197.69% YoY

As of Jun 30, 2026

Annual EBIT (TTM)

-$67.27B
↓ 356.21% YoY

Trailing 12 months ending Jun 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

LabGenomics , Ltd. (084650.KQ) FAQ

As of the most recent data (June 2026), 084650.KQ shows a EBIT of $-67B. That compares with $-15B in the prior-year period — down 356.2% year over year. That is below the sector sector average of $2.4T. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 084650.KQ's EBIT is now $-67B (was $-15B) — a 356.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether LabGenomics , Ltd. is outperforming or lagging.

The its sector sector average EBIT is about $2.4T. LabGenomics , Ltd. is at $-67B, which is lower that average. That is roughly 102.8% below the sector mean. Use the comparison chart on this page to see how 084650.KQ stacks up against individual peers as well.

Tracking 084650.KQ's ebit over time shows whether LabGenomics , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $-67B That compares with $-15B in the prior-year period — down 356.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has LabGenomics , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-67B) with ownership activity and broader fundamentals.